Publicaciones en las que colabora con ROSA NOGUERA SALVA (84)

2024

  1. Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines

    Cancers, Vol. 16, Núm. 19

  2. Real-time morphometric analysis of targeted therapy for neuroblastoma cells in monolayer and 3D hydrogels using digital holographic microscopy

    iScience, Vol. 27, Núm. 11

  3. Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?

    International Journal of Molecular Sciences, Vol. 25, Núm. 16

2023

  1. Digital image analysis workflows for evaluation of cell behavior and tumor microenvironment to aid therapeutic assessment in high-risk neuroblastoma

    Computers in Biology and Medicine, Vol. 164

2022

  1. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

    Frontiers in Cell and Developmental Biology, Vol. 9

  2. Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes

    Neoplasia (United States), Vol. 23, Núm. 1, pp. 12-20

  3. Intra-tumour genetic heterogeneity and prognosis in high-risk neuroblastoma

    Cancers, Vol. 13, Núm. 20

  4. Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma

    International Journal of Pharmaceutics, Vol. 608

2020

  1. A three-dimensional bioprinted model to evaluate the effect of stiffness on neuroblastoma cell cluster dynamics and behavior

    Scientific Reports, Vol. 10, Núm. 1

  2. Digital image analysis applied to tumor cell proliferation, aggressiveness, and migration-related protein synthesis in neuroblastoma 3d models

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-17

  3. Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line

    Journal of Experimental and Clinical Cancer Research, Vol. 39, Núm. 1

  4. The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer-aided detection

    International Journal of Cancer, Vol. 146, Núm. 2, pp. 553-565

2019

  1. Extra-Adrenal Adult Neuroblastoma With Aberrant Germ Cell Marker Expression: Maturation After Chemotherapy as an Important Clue to a Challenging Diagnosis

    International Journal of Surgical Pathology, Vol. 27, Núm. 5, pp. 568-573

  2. High Oct4 expression: Implications in the pathogenesis of neuroblastic tumours

    BMC Cancer, Vol. 19, Núm. 1

  3. Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma

    BMC Cancer, Vol. 19, Núm. 1

2018

  1. 1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors

    Histology and Histopathology, Vol. 33, Núm. 5, pp. 487-495

  2. 9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma

    Anti-Cancer Drugs, Vol. 29, Núm. 8, pp. 717-724

  3. Heterogeneous MYCN amplification in neuroblastoma: A SIOP Europe Neuroblastoma Study

    British Journal of Cancer, Vol. 118, Núm. 11, pp. 1502-1512

  4. Lymph microvascularization as a prognostic indicator in neuroblastoma

    Oncotarget, Vol. 9, Núm. 40, pp. 26157-26170